Found: 22
Select item for more details and to access through your institution.
The Power Transition under the Interaction of Different Systems—A Case Study of the Guangdong–Hong Kong–Macao Greater Bay Area.
- Published in:
- Sustainability (2071-1050), 2023, v. 15, n. 6, p. 5577, doi. 10.3390/su15065577
- By:
- Publication type:
- Article
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, p. N.PAG, doi. 10.1038/s41392-020-00221-8
- By:
- Publication type:
- Article
Expression Analysis and Serodiagnostic Potential of Microneme Proteins 1 and 3 in Eimeria stiedai.
- Published in:
- Genes, 2020, v. 11, n. 7, p. 725, doi. 10.3390/genes11070725
- By:
- Publication type:
- Article
The landscape of m<sup>6</sup>A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01408-5
- By:
- Publication type:
- Article
Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01022-x
- By:
- Publication type:
- Article
RNA N<sup>6</sup>‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 9, p. 1, doi. 10.1002/ctm2.525
- By:
- Publication type:
- Article
Tumor‐infiltrating CD8<sup>+</sup> T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 6, p. 1, doi. 10.1002/ctm2.456
- By:
- Publication type:
- Article
A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 4, p. 1, doi. 10.1002/ctm2.156
- By:
- Publication type:
- Article
The potential role of N<sup>7</sup>-methylguanosine (m7G) in cancer.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01285-5
- By:
- Publication type:
- Article
m<sup>6</sup>A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01173-4
- By:
- Publication type:
- Article
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 943, doi. 10.1007/s00432-021-03659-7
- By:
- Publication type:
- Article
Utilizing MapReduce to Improve Probe-Car Track Data Mining.
- Published in:
- ISPRS International Journal of Geo-Information, 2018, v. 7, n. 7, p. 287, doi. 10.3390/ijgi7070287
- By:
- Publication type:
- Article
TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 12, p. 1755, doi. 10.1093/carcin/bgaa038
- By:
- Publication type:
- Article
An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-02357-1
- By:
- Publication type:
- Article
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03625-x
- By:
- Publication type:
- Article
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 617, doi. 10.1007/s00262-022-03280-8
- By:
- Publication type:
- Article
Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs.
- Published in:
- Biomedicines, 2023, v. 11, n. 4, p. 1141, doi. 10.3390/biomedicines11041141
- By:
- Publication type:
- Article
m<sup>6</sup>A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.745769
- By:
- Publication type:
- Article
Comprehensive analyses of N<sup>6</sup>‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4289, doi. 10.1111/cas.15553
- By:
- Publication type:
- Article